scispace - formally typeset
Search or ask a question

Showing papers by "University at Buffalo published in 2021"


Journal ArticleDOI
TL;DR: In this article, the authors present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes.
Abstract: In 2008, we published the first set of guidelines for standardizing research in autophagy. Since then, this topic has received increasing attention, and many scientists have entered the field. Our knowledge base and relevant new technologies have also been expanding. Thus, it is important to formulate on a regular basis updated guidelines for monitoring autophagy in different organisms. Despite numerous reviews, there continues to be confusion regarding acceptable methods to evaluate autophagy, especially in multicellular eukaryotes. Here, we present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes. These guidelines are not meant to be a dogmatic set of rules, because the appropriateness of any assay largely depends on the question being asked and the system being used. Moreover, no individual assay is perfect for every situation, calling for the use of multiple techniques to properly monitor autophagy in each experimental setting. Finally, several core components of the autophagy machinery have been implicated in distinct autophagic processes (canonical and noncanonical autophagy), implying that genetic approaches to block autophagy should rely on targeting two or more autophagy-related genes that ideally participate in distinct steps of the pathway. Along similar lines, because multiple proteins involved in autophagy also regulate other cellular pathways including apoptosis, not all of them can be used as a specific marker for bona fide autophagic responses. Here, we critically discuss current methods of assessing autophagy and the information they can, or cannot, provide. Our ultimate goal is to encourage intellectual and technical innovation in the field.

1,129 citations


Book
08 Jun 2021
TL;DR: A history of general systems theory can be found in this article, where the notion of general system theory first emerged from the pre-Socra... and discusses several of its various aspects.
Abstract: The article presents a history of general systems theory and discusses several of its various aspects. According to the author, the notion of general systems theory first stemmed from the pre-Socra...

769 citations


Journal ArticleDOI
TL;DR: It is indicated that allostatic load and overload are associated with poorer health outcomes and an integrated approach that includes both biological markers and clinimetric criteria is recommended.
Abstract: Introduction: Allostatic load refers to the cumulative burden of chronic stress and life events. It involves the interaction of different physiological systems at varying degrees of activity. When environmental challenges exceed the individual ability to cope, then allostatic overload ensues. Allostatic load is identified by the use of biomarkers and clinical criteria. Objective: To summarize the current knowledge on allostatic load and overload and its clinical implications based on a systematic review of the literature. Methods: PubMed, PsycINFO, Web of Science, and the Cochrane Library were searched from inception to December 2019. A manual search of the literature was also performed, and reference lists of the retrieved articles were examined.We considered only studies in which allostatic load or overload were adequately described and assessed in either clinical or non-clinical adult populations. Results: A total of 267 original investigations were included. They encompassed general population studies, as well as clinical studies on consequences of allostatic load/overload on both physical and mental health across a variety of settings. Conclusions: The findings indicate that allostatic load and overload are associated with poorer health outcomes. Assessment of allostatic load provides support to the understanding of psychosocial determinants of health and lifestyle medicine. An integrated approach that includes both biological markers and clinimetric criteria is recommended.

336 citations


Journal ArticleDOI
TL;DR: A novel case of CO VID-19 is described in a previously healthy 33-year-old female who presented for altered mental status and proptosis and was ultimately diagnosed with mucormycosis and orbital compartment syndrome, in addition to COVID-19.
Abstract: During the current pandemic of COVID-19, a myriad of manifestations and complications has emerged and are being reported on. We are discovering patients with COVID-19 are at increased risk of acute cardiac injury, arrythmias, thromboembolic complications (pulmonary embolism and acute stroke), and secondary infection to name a few. I describe a novel case of COVID-19 in a previously healthy 33-year-old female who presented for altered mental status and proptosis. She was ultimately diagnosed with mucormycosis and orbital compartment syndrome, in addition to COVID-19. Early identification of these high morbidity conditions is key to allow for optimal treatment and improved outcomes.

289 citations


Journal ArticleDOI
TL;DR: The Surviving Sepsis Campaign Coronavirus Diease 2019 (SCCD) 2019 panel as mentioned in this paper provided guidance on the management of patients with severe or critical coronavirus disease 2019 in the ICU.
Abstract: Background The coronavirus disease 2019 pandemic continues to affect millions worldwide. Given the rapidly growing evidence base, we implemented a living guideline model to provide guidance on the management of patients with severe or critical coronavirus disease 2019 in the ICU. Methods The Surviving Sepsis Campaign Coronavirus Disease 2019 panel has expanded to include 43 experts from 14 countries; all panel members completed an electronic conflict-of-interest disclosure form. In this update, the panel addressed nine questions relevant to managing severe or critical coronavirus disease 2019 in the ICU. We used the World Health Organization's definition of severe and critical coronavirus disease 2019. The systematic reviews team searched the literature for relevant evidence, aiming to identify systematic reviews and clinical trials. When appropriate, we performed a random-effects meta-analysis to summarize treatment effects. We assessed the quality of the evidence using the Grading of Recommendations, Assessment, Development, and Evaluation approach, then used the evidence-to-decision framework to generate recommendations based on the balance between benefit and harm, resource and cost implications, equity, and feasibility. Results The Surviving Sepsis Campaign Coronavirus Diease 2019 panel issued nine statements (three new and six updated) related to ICU patients with severe or critical coronavirus disease 2019. For severe or critical coronavirus disease 2019, the panel strongly recommends using systemic corticosteroids and venous thromboprophylaxis but strongly recommends against using hydroxychloroquine. In addition, the panel suggests using dexamethasone (compared with other corticosteroids) and suggests against using convalescent plasma and therapeutic anticoagulation outside clinical trials. The Surviving Sepsis Campaign Coronavirus Diease 2019 panel suggests using remdesivir in nonventilated patients with severe coronavirus disease 2019 and suggests against starting remdesivir in patients with critical coronavirus disease 2019 outside clinical trials. Because of insufficient evidence, the panel did not issue a recommendation on the use of awake prone positioning. Conclusion The Surviving Sepsis Campaign Coronavirus Diease 2019 panel issued several recommendations to guide healthcare professionals caring for adults with critical or severe coronavirus disease 2019 in the ICU. Based on a living guideline model the recommendations will be updated as new evidence becomes available.

257 citations


Journal ArticleDOI
Valery L. Feigin1, Valery L. Feigin2, Theo Vos1, Theo Vos3, Fares Alahdab4, Arianna Maever L. Amit5, Arianna Maever L. Amit6, Till Bärnighausen7, Till Bärnighausen8, Ettore Beghi9, Mahya Beheshti10, Prachi Chavan11, Michael H. Criqui12, Rupak Desai13, Samath D Dharmaratne14, Samath D Dharmaratne3, Samath D Dharmaratne1, E. Ray Dorsey15, Arielle Wilder Eagan16, Arielle Wilder Eagan8, Islam Y. Elgendy8, Irina Filip17, Irina Filip18, Simona Giampaoli19, Giorgia Giussani9, Nima Hafezi-Nejad6, Nima Hafezi-Nejad20, Michael K. Hole21, Takayoshi Ikeda2, Catherine O. Johnson1, Rizwan Kalani3, Khaled Khatab22, Khaled Khatab23, Jagdish Khubchandani24, Daniel Kim25, Walter J. Koroshetz, Vijay Krishnamoorthy3, Vijay Krishnamoorthy26, Rita Krishnamurthi2, Xuefeng Liu27, Warren D. Lo28, Warren D. Lo29, Giancarlo Logroscino30, George A. Mensah31, George A. Mensah32, Ted R. Miller33, Ted R. Miller34, Salahuddin Mohammed35, Salahuddin Mohammed36, Ali H. Mokdad1, Ali H. Mokdad3, Maziar Moradi-Lakeh37, Shane D. Morrison27, Veeresh Kumar N. Shivamurthy38, Mohsen Naghavi1, Mohsen Naghavi3, Emma Nichols1, Bo Norrving39, Christopher M Odell1, Elisabetta Pupillo9, Amir Radfar40, Gregory A. Roth3, Gregory A. Roth1, Azadeh Shafieesabet41, Aziz Sheikh42, Aziz Sheikh8, Sara Sheikhbahaei6, Jae Il Shin43, Jasvinder A. Singh44, Jasvinder A. Singh45, Timothy J. Steiner46, Timothy J. Steiner47, Lars Jacob Stovner47, Mitchell T. Wallin48, Mitchell T. Wallin49, Jordan Weiss50, Chenkai Wu26, Joseph R. Zunt3, Jaimie D. Adelson1, Christopher J L Murray1, Christopher J L Murray3 
TL;DR: A large and increasing number of people have various neurological disorders in the US, with significant variation in the burden of and trends in neurological disorders across the US states, and the reasons for these geographic variations need to be explored further.
Abstract: IMPORTANCE Accurate and up-to-date estimates on incidence, prevalence, mortality, and disability-adjusted life-years (burden) of neurological disorders are the backbone of evidence-based health care planning and resource allocation for these disorders. It appears that no such estimates have been reported at the state level for the US. OBJECTIVE To present burden estimates of major neurological disorders in the US states by age and sex from 1990 to 2017. DESIGN, SETTING, AND PARTICIPANTS This is a systematic analysis of the Global Burden of Disease (GBD) 2017 study. Data on incidence, prevalence, mortality, and disability-adjusted life-years (DALYs) of major neurological disorders were derived from the GBD 2017 study of the 48 contiguous US states, Alaska, and Hawaii. Fourteen major neurological disorders were analyzed: stroke, Alzheimer disease and other dementias, Parkinson disease, epilepsy, multiple sclerosis, motor neuron disease, migraine, tension-type headache, traumatic brain injury, spinal cord injuries, brain and other nervous system cancers, meningitis, encephalitis, and tetanus. EXPOSURES Any of the 14 listed neurological diseases. MAIN OUTCOME AND MEASURE Absolute numbers in detail by age and sex and age-standardized rates (with 95% uncertainty intervals) were calculated. RESULTS The 3 most burdensome neurological disorders in the US in terms of absolute number of DALYs were stroke (3.58 [95% uncertainty interval [UI], 3.25-3.92] million DALYs), Alzheimer disease and other dementias (2.55 [95% UI, 2.43-2.68] million DALYs), and migraine (2.40 [95% UI, 1.53-3.44] million DALYs). The burden of almost all neurological disorders (in terms of absolute number of incident, prevalent, and fatal cases, as well as DALYs) increased from 1990 to 2017, largely because of the aging of the population. Exceptions for this trend included traumatic brain injury incidence (−29.1% [95% UI, −32.4% to −25.8%]); spinal cord injury prevalence (−38.5% [95% UI, −43.1% to −34.0%]); meningitis prevalence (−44.8% [95% UI, −47.3% to −42.3%]), deaths (−64.4% [95% UI, −67.7% to −50.3%]), and DALYs (−66.9% [95% UI, −70.1% to −55.9%]); and encephalitis DALYs (−25.8% [95% UI, −30.7% to −5.8%]). The different metrics of age-standardized rates varied between the US states from a 1.2-fold difference for tension-type headache to 7.5-fold for tetanus; southeastern states and Arkansas had a relatively higher burden for stroke, while northern states had a relatively higher burden of multiple sclerosis and eastern states had higher rates of Parkinson disease, idiopathic epilepsy, migraine and tension-type headache, and meningitis, encephalitis, and tetanus. CONCLUSIONS AND RELEVANCE There is a large and increasing burden of noncommunicable neurological disorders in the US, with up to a 5-fold variation in the burden of and trends in particular neurological disorders across the US states. The information reported in this article can be used by health care professionals and policy makers at the national and state levels to advance their health care planning and resource allocation to prevent and reduce the burden of neurological disorders.

212 citations


Proceedings ArticleDOI
01 Jun 2021
TL;DR: Wu et al. as discussed by the authors proposed TraDeS (TRAck to DEtect and Segment), which infers object tracking offset by a cost volume, which is used to propagate previous object features for improving object detection and segmentation.
Abstract: Most online multi-object trackers perform object detection stand-alone in a neural net without any input from tracking. In this paper, we present a new online joint detection and tracking model, TraDeS (TRAck to DEtect and Segment), exploiting tracking clues to assist detection end-to-end. TraDeS infers object tracking offset by a cost volume, which is used to propagate previous object features for improving current object detection and segmentation. Effectiveness and superiority of TraDeS are shown on 4 datasets, including MOT (2D tracking), nuScenes (3D tracking), MOTS and Youtube-VIS (instance segmentation tracking). Project page: https://jialianwu.com/projects/TraDeS.html.

184 citations


Journal ArticleDOI
TL;DR: In this article, the authors provided evidence-based recommendations and expert guidance for the management of antineutrophil cytoplasmic antibody-associated vasculitis (AAV), including granulomatosis with polyangiitis (GPA), microscopic polyangisitis (MPA), and eosinophilic granulomas with polyanagliitis (EGPA), which required ≥70% consensus among the Voting Panel.
Abstract: Objective To provide evidence-based recommendations and expert guidance for the management of antineutrophil cytoplasmic antibody-associated vasculitis (AAV), including granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA). Methods Clinical questions regarding the treatment and management of AAV were developed in the population, intervention, comparator, and outcome (PICO) format (47 for GPA/MPA, 34 for EGPA). Systematic literature reviews were conducted for each PICO question. The Grading of Recommendations Assessment, Development and Evaluation methodology was used to assess the quality of evidence and formulate recommendations. Each recommendation required ≥70% consensus among the Voting Panel. Results We present 26 recommendations and 5 ungraded position statements for GPA/MPA, and 15 recommendations and 5 ungraded position statements for EGPA. This guideline provides recommendations for remission induction and maintenance therapy as well as adjunctive treatment strategies in GPA, MPA, and EGPA. These recommendations include the use of rituximab for remission induction and maintenance in severe GPA and MPA and the use of mepolizumab in nonsevere EGPA. All recommendations are conditional due in part to the lack of multiple randomized controlled trials and/or low-quality evidence supporting the recommendations. Conclusion This guideline presents the first recommendations endorsed by the American College of Rheumatology and the Vasculitis Foundation for the management of AAV and provides guidance to health care professionals on how to treat these diseases.

174 citations


Journal ArticleDOI
TL;DR: The International Classification of Retinopathy of Prematurity, Third Edition (ICROP3) as discussed by the authors is a consensus statement that creates a standard nomenclature for classification of ROP.

171 citations


Journal ArticleDOI
TL;DR: An image fusion-based algorithm to enhance the performance and robustness of image dehazing is proposed, based on a set of gamma-corrected underexposed images, and pixelwise weight maps are constructed by analyzing both global and local exposedness to guide the fusion process.
Abstract: Poor weather conditions, such as fog, haze, and mist, cause visibility degradation in captured images. Existing imaging devices lack the ability to effectively and efficiently mitigate the visibility degradation caused by poor weather conditions in real time. Image depth information is used to eliminate hazy effects by using existing physical model-based approaches. However, the imprecise depth information always affects dehazing performance. This article proposes an image fusion-based algorithm to enhance the performance and robustness of image dehazing. Based on a set of gamma-corrected underexposed images, pixelwise weight maps are constructed by analyzing both global and local exposedness to guide the fusion process. The spatial-dependence of luminance of the fused image is reduced, and its color saturation is balanced in the dehazing process. The performance of the proposed solution is confirmed in both theoretical analysis and comparative experiments.

150 citations


Journal ArticleDOI
TL;DR: In this paper, the authors provide evidence-based recommendations and expert guidance for the management of giant cell arteritis (GCA) and Takayasu arteritis as exemplars of large vessel vasculitis.
Abstract: Objective To provide evidence-based recommendations and expert guidance for the management of giant cell arteritis (GCA) and Takayasu arteritis (TAK) as exemplars of large vessel vasculitis. Methods Clinical questions regarding diagnostic testing, treatment, and management were developed in the population, intervention, comparator, and outcome (PICO) format for GCA and TAK (27 for GCA, 27 for TAK). Systematic literature reviews were conducted for each PICO question. The Grading of Recommendations Assessment, Development and Evaluation methodology was used to rate the quality of the evidence. Recommendations were developed by the Voting Panel, comprising adult and pediatric rheumatologists and patients. Each recommendation required ≥70% consensus among the Voting Panel. Results We present 22 recommendations and 2 ungraded position statements for GCA, and 20 recommendations and 1 ungraded position statement for TAK. These recommendations and statements address clinical questions relating to the use of diagnostic testing, including imaging, treatments, and surgical interventions in GCA and TAK. Recommendations for GCA include support for the use of glucocorticoid-sparing immunosuppressive agents and the use of imaging to identify large vessel involvement. Recommendations for TAK include the use of nonglucocorticoid immunosuppressive agents with glucocorticoids as initial therapy. There were only 2 strong recommendations; the remaining recommendations were conditional due to the low quality of evidence available for most PICO questions. Conclusion These recommendations provide guidance regarding the evaluation and management of patients with GCA and TAK, including diagnostic strategies, use of pharmacologic agents, and surgical interventions.

Journal ArticleDOI
TL;DR: In this paper, a survey was conducted to assess the influences of risk perception and fear associated with COVID-19, beliefs about and attitudes toward COVID19 vaccines, self-efficacy, social and psychological contexts, and demographic characteristics.

Journal ArticleDOI
TL;DR: This review summarizes the recent advances in the development of photoclick reactions and their applications in chemical biology and materials science and places a particular emphasis on the historical contexts and mechanistic insights into each of the selected reactions.
Abstract: The merging of click chemistry with discrete photochemical processes has led to the creation of a new class of click reactions, collectively known as photoclick chemistry. These light-triggered click reactions allow the synthesis of diverse organic structures in a rapid and precise manner under mild conditions. Because light offers unparalleled spatiotemporal control over the generation of the reactive intermediates, photoclick chemistry has become an indispensable tool for a wide range of spatially addressable applications including surface functionalization, polymer conjugation and cross-linking, and biomolecular labeling in the native cellular environment. Over the past decade, a growing number of photoclick reactions have been developed, especially those based on the 1,3-dipolar cycloadditions and Diels-Alder reactions owing to their excellent reaction kinetics, selectivity, and biocompatibility. This review summarizes the recent advances in the development of photoclick reactions and their applications in chemical biology and materials science. A particular emphasis is placed on the historical contexts and mechanistic insights into each of the selected reactions. The in-depth discussion presented here should stimulate further development of the field, including the design of new photoactivation modalities, the continuous expansion of λ-orthogonal tandem photoclick chemistry, and the innovative use of these unique tools in bioconjugation and nanomaterial synthesis.

Journal ArticleDOI
Albert M. Sirunyan, Armen Tumasyan, Wolfgang Adam1, Thomas Bergauer1  +2405 moreInstitutions (229)
TL;DR: In this paper, the performance of the reconstruction and identification algorithms for electrons and photons with the CMS experiment at the LHC is presented, based on proton-proton collision data collected at a center-of-mass energy of 13 TeV and recorded in 2016-2018, corresponding to an integrated luminosity of 136 fb$^{-1}$.
Abstract: The performance is presented of the reconstruction and identification algorithms for electrons and photons with the CMS experiment at the LHC. The reported results are based on proton-proton collision data collected at a center-of-mass energy of 13 TeV and recorded in 2016-2018, corresponding to an integrated luminosity of 136 fb$^{-1}$. Results obtained from lead-lead collision data collected at $\sqrt{s_\mathrm{NN}}=$ 5.02 TeV are also presented. Innovative techniques are used to reconstruct the electron and photon signals in the detector and to optimize the energy resolution. Events with electrons and photons in the final state are used to measure the energy resolution and energy scale uncertainty in the recorded events. The measured energy resolution for electrons produced in Z boson decays in proton-proton collision data ranges from 2 to 5%, depending on electron pseudorapidity and energy loss through bremsstrahlung in the detector material. The energy scale in the same range of energies is measured with an uncertainty smaller than 0.1 (0.3)% in the barrel (endcap) region in proton-proton collisions and better than 1 (3)% in the barrel (endcap) region in heavy ion collisions. The timing resolution for electrons from Z boson decays with the full 2016-2018 proton-proton collision data set is measured to be 200 ps.

Journal ArticleDOI
Tamsin L. Edwards1, Sophie Nowicki2, Sophie Nowicki3, Ben Marzeion4, Regine Hock5, Regine Hock6, Heiko Goelzer7, Heiko Goelzer8, Heiko Goelzer9, Helene Seroussi10, Nicolas C. Jourdain11, Donald Slater12, Donald Slater13, Donald Slater14, Fiona Turner1, Christopher J. Smith15, Christopher J. Smith16, Christine M. McKenna15, Erika Simon3, Ayako Abe-Ouchi17, Jonathan M. Gregory18, Jonathan M. Gregory19, Eric Larour10, William H. Lipscomb20, Antony J. Payne21, Andrew Shepherd15, Cécile Agosta22, Patrick Alexander23, Patrick Alexander24, Torsten Albrecht25, Brian Anderson26, Xylar Asay-Davis27, Andy Aschwanden6, Alice Barthel27, Andrew Bliss28, Reinhard Calov25, Christopher Chambers29, Nicolas Champollion11, Nicolas Champollion4, Youngmin Choi10, Youngmin Choi30, Richard I. Cullather3, J. K. Cuzzone10, Christophe Dumas22, Denis Felikson31, Denis Felikson3, Xavier Fettweis32, Koji Fujita33, Benjamin K. Galton-Fenzi34, Benjamin K. Galton-Fenzi35, Rupert Gladstone36, Nicholas R. Golledge26, Ralf Greve29, Tore Hattermann37, Tore Hattermann38, Matthew J. Hoffman27, Angelika Humbert39, Angelika Humbert4, Matthias Huss40, Matthias Huss41, Matthias Huss42, Philippe Huybrechts43, Walter W. Immerzeel9, Thomas Kleiner39, Philip Kraaijenbrink9, Sébastien Le clec'h43, Victoria Lee21, Gunter R. Leguy20, Christopher M. Little, Daniel P. Lowry44, Jan Hendrik Malles4, Daniel F. Martin45, Fabien Maussion46, Mathieu Morlighem30, James F. O’Neill1, Isabel Nias47, Isabel Nias3, Frank Pattyn8, Tyler Pelle30, Stephen Price27, Aurélien Quiquet22, Valentina Radić48, Ronja Reese25, David R. Rounce49, David R. Rounce6, Martin Rückamp39, Akiko Sakai33, Courtney Shafer45, Nicole Schlegel10, Sarah Shannon21, Robin S. Smith18, Fiammetta Straneo13, Sainan Sun8, Lev Tarasov50, Luke D. Trusel51, Jonas Van Breedam43, Roderik S. W. van de Wal9, Michiel R. van den Broeke9, Ricarda Winkelmann25, Ricarda Winkelmann52, Harry Zekollari, Cheng Zhao34, Tong Zhang27, Tong Zhang53, Thomas Zwinger54 
King's College London1, University at Buffalo2, Goddard Space Flight Center3, University of Bremen4, University of Oslo5, University of Alaska Fairbanks6, Bjerknes Centre for Climate Research7, Université libre de Bruxelles8, Utrecht University9, California Institute of Technology10, University of Grenoble11, University of Edinburgh12, University of California, San Diego13, University of St Andrews14, University of Leeds15, International Institute for Applied Systems Analysis16, University of Tokyo17, University of Reading18, Met Office19, National Center for Atmospheric Research20, University of Bristol21, Université Paris-Saclay22, Columbia University23, Goddard Institute for Space Studies24, Potsdam Institute for Climate Impact Research25, Victoria University of Wellington26, Los Alamos National Laboratory27, Colorado State University28, Hokkaido University29, University of California, Irvine30, Universities Space Research Association31, University of Liège32, Nagoya University33, University of Tasmania34, Australian Antarctic Division35, University of Lapland36, University of Tromsø37, Norwegian Polar Institute38, Alfred Wegener Institute for Polar and Marine Research39, ETH Zurich40, University of Fribourg41, Swiss Federal Institute for Forest, Snow and Landscape Research42, Vrije Universiteit Brussel43, GNS Science44, Lawrence Berkeley National Laboratory45, University of Innsbruck46, University of Liverpool47, University of British Columbia48, Carnegie Mellon University49, Memorial University of Newfoundland50, Pennsylvania State University51, University of Potsdam52, Beijing Normal University53, CSC – IT Center for Science54
06 May 2021-Nature
TL;DR: In this article, the authors estimate probability distributions for these projections under the new scenarios using statistical emulation of the ice sheet and glacier models, and find that limiting global warming to 1.5 degrees Celsius would halve the land ice contribution to twenty-first-century sea level rise, relative to current emissions pledges.
Abstract: The land ice contribution to global mean sea level rise has not yet been predicted1 using ice sheet and glacier models for the latest set of socio-economic scenarios, nor using coordinated exploration of uncertainties arising from the various computer models involved. Two recent international projects generated a large suite of projections using multiple models2,3,4,5,6,7,8, but primarily used previous-generation scenarios9 and climate models10, and could not fully explore known uncertainties. Here we estimate probability distributions for these projections under the new scenarios11,12 using statistical emulation of the ice sheet and glacier models. We find that limiting global warming to 1.5 degrees Celsius would halve the land ice contribution to twenty-first-century sea level rise, relative to current emissions pledges. The median decreases from 25 to 13 centimetres sea level equivalent (SLE) by 2100, with glaciers responsible for half the sea level contribution. The projected Antarctic contribution does not show a clear response to the emissions scenario, owing to uncertainties in the competing processes of increasing ice loss and snowfall accumulation in a warming climate. However, under risk-averse (pessimistic) assumptions, Antarctic ice loss could be five times higher, increasing the median land ice contribution to 42 centimetres SLE under current policies and pledges, with the 95th percentile projection exceeding half a metre even under 1.5 degrees Celsius warming. This would severely limit the possibility of mitigating future coastal flooding. Given this large range (between 13 centimetres SLE using the main projections under 1.5 degrees Celsius warming and 42 centimetres SLE using risk-averse projections under current pledges), adaptation planning for twenty-first-century sea level rise must account for a factor-of-three uncertainty in the land ice contribution until climate policies and the Antarctic response are further constrained.

Journal ArticleDOI
01 Sep 2021
TL;DR: In this paper, the authors discuss the specific challenges and opportunities related to materials discovery and development that will emerge from this new paradigm and outline the current status, barriers and needed investments, culminating with a vision for the path forward.
Abstract: Summary Solutions to many of the world's problems depend upon materials research and development. However, advanced materials can take decades to discover and decades more to fully deploy. Humans and robots have begun to partner to advance science and technology orders of magnitude faster than humans do today through the development and exploitation of closed-loop, autonomous experimentation systems. This review discusses the specific challenges and opportunities related to materials discovery and development that will emerge from this new paradigm. Our perspective incorporates input from stakeholders in academia, industry, government laboratories, and funding agencies. We outline the current status, barriers, and needed investments, culminating with a vision for the path forward. We intend the article to spark interest in this emerging research area and to motivate potential practitioners by illustrating early successes. We also aspire to encourage a creative reimagining of the next generation of materials science infrastructure. To this end, we frame future investments in materials science and technology, hardware and software infrastructure, artificial intelligence and autonomy methods, and critical workforce development for autonomous research.

Journal ArticleDOI
TL;DR: In this paper, the synthesis of yttrium superhydrides with room-temperature superconductivity at a critical temperature of 262 K at 182±8 8 ωGPa was reported.
Abstract: The recent observation of room-temperature superconductivity will undoubtedly lead to a surge in the discovery of new, dense, hydrogen-rich materials. The rare earth metal superhydrides are predicted to have very high-T_{c} superconductivity that is tunable with changes in stoichiometry or doping. Here we report the synthesis of an yttrium superhydride that exhibits superconductivity at a critical temperature of 262 K at 182±8 GPa. A palladium thin film assists the synthesis by protecting the sputtered yttrium from oxidation and promoting subsequent hydrogenation. Phonon-mediated superconductivity is established by the observation of zero resistance, an isotope effect and the reduction of T_{c} under an external magnetic field. The upper critical magnetic field is 103 T at zero temperature.

Journal ArticleDOI
TL;DR: In this paper, a ternary system comprising of a prion-like polypeptide (PLP), arginine-rich polypeptic (RRP), and RNA was used to demix the two types of biomolecular condensates into stable coexisting phases.
Abstract: Multivalent protein-protein and protein-RNA interactions are the drivers of biological phase separation Biomolecular condensates typically contain a dense network of multiple proteins and RNAs, and their competing molecular interactions play key roles in regulating the condensate composition and structure Employing a ternary system comprising of a prion-like polypeptide (PLP), arginine-rich polypeptide (RRP), and RNA, we show that competition between the PLP and RNA for a single shared partner, the RRP, leads to RNA-induced demixing of PLP-RRP condensates into stable coexisting phases—homotypic PLP condensates and heterotypic RRP-RNA condensates The morphology of these biphasic condensates (non-engulfing/ partial engulfing/ complete engulfing) is determined by the RNA-to-RRP stoichiometry and the hierarchy of intermolecular interactions, providing a glimpse of the broad range of multiphasic patterns that are accessible to these condensates Our findings provide a minimal set of physical rules that govern the composition and spatial organization of multicomponent and multiphasic biomolecular condensates Liquid ribonucleoprotein condensates typically involve a dense network of multiple proteins and RNAs Here, the authors employ a minimal system composed of Prion-like polypeptides (PLP), Arg-rich polypeptides (RRP), and RNA to form biphasic condensates with diverse morphologies tunable via mixture stoichiometry and hierarchy of intermolecular interactions

Journal ArticleDOI
TL;DR: The use of corticosteroids probably reduced mortality in patients with ARDS of any etiology (2740 patients in 16 trials, RR 0.82, 95% CI 0.72-0.95, ARR 8.0%, 95%CI 2.2-12.5%, moderate certainty).
Abstract: Corticosteroids are now recommended for patients with severe COVID-19 including those with COVID-related ARDS. This has generated renewed interest regarding whether corticosteroids should be used in non-COVID ARDS as well. The objective of this study was to summarize all RCTs examining the use of corticosteroids in ARDS. The protocol of this study was pre-registered on PROSPERO (CRD42020200659). We searched online databases including MEDLINE, EMBASE, CDC library of COVID research, CINAHL, and COCHRANE. We included RCTs that compared the effect of corticosteroids to placebo or usual care in adult patients with ARDS, including patients with COVID-19. Three reviewers abstracted data independently and in duplicate using a pre-specified standardized form. We assessed individual study risk of bias using the revised Cochrane ROB-2 tool and rated certainty in outcomes using GRADE methodology. We pooled data using a random effects model. The main outcome for this review was 28-day-mortality. We included 18 RCTs enrolling 2826 patients. The use of corticosteroids probably reduced mortality in patients with ARDS of any etiology (2740 patients in 16 trials, RR 0.82, 95% CI 0.72–0.95, ARR 8.0%, 95% CI 2.2–12.5%, moderate certainty). Patients who received a longer course of corticosteroids (over 7 days) had higher rates of survival compared to a shorter course. The use of corticosteroids probably reduces mortality in patients with ARDS. This effect was consistent between patients with COVID-19 and non-COVID-19 ARDS, corticosteroid types, and dosage.

Journal ArticleDOI
TL;DR: In this paper, the effect of extrusion nozzle size, Cartesian print speed, and fiber volume fraction on the orientation of steel fibers in 3D printed ultra-high performance concrete was evaluated using digital image analysis.

Book ChapterDOI
TL;DR: In this article, the authors proposed that the tinnitus without and with associated suffering should be differentiated by distinct terms: "Tinnitus" for the former and Tinnitus Disorder for the latter, which is the conscious awareness of a tonal or composite noise for which there is no identifiable corresponding external acoustic source.
Abstract: As for hypertension, chronic pain, epilepsy and other disorders with particular symptoms, a commonly accepted and unambiguous definition provides a common ground for researchers and clinicians to study and treat the problem. The WHO's ICD11 definition only mentions tinnitus as a nonspecific symptom of a hearing disorder, but not as a clinical entity in its own right, and the American Psychiatric Association's DSM-V doesn't mention tinnitus at all. Here we propose that the tinnitus without and with associated suffering should be differentiated by distinct terms: "Tinnitus" for the former and "Tinnitus Disorder" for the latter. The proposed definition then becomes "Tinnitus is the conscious awareness of a tonal or composite noise for which there is no identifiable corresponding external acoustic source, which becomes Tinnitus Disorder "when associated with emotional distress, cognitive dysfunction, and/or autonomic arousal, leading to behavioural changes and functional disability.". In other words "Tinnitus" describes the auditory or sensory component, whereas "Tinnitus Disorder" reflects the auditory component and the associated suffering. Whereas acute tinnitus may be a symptom secondary to a trauma or disease, chronic tinnitus may be considered a primary disorder in its own right. If adopted, this will advance the recognition of tinnitus disorder as a primary health condition in its own right. The capacity to measure the incidence, prevalence, and impact will help in identification of human, financial, and educational needs required to address acute tinnitus as a symptom but chronic tinnitus as a disorder.

Journal ArticleDOI
TL;DR: This research presents a novel and scalable approach called “SmartGlass” that automates the very labor-intensive and therefore time-heavy and expensive and expensive process of manually cataloging and displaying information in augmented reality (AR).
Abstract: Augmented reality (AR) has proven to be an invaluable interactive medium to reduce cognitive load by bridging the gap between the task-at-hand and relevant information by displaying information wit...

Journal ArticleDOI
TL;DR: The X-Phi Replicability Project (XRP) as discussed by the authors was formed to estimate the reproducibility of experimental philosophy (osf.io/dvkpr) studies published between 2003 and 2015 and recruited 20 research teams across 8 countries to conduct a high-quality replication of each study in order to compare the results to the original published findings.
Abstract: Responding to recent concerns about the reliability of the published literature in psychology and other disciplines, we formed the X-Phi Replicability Project (XRP) to estimate the reproducibility of experimental philosophy (osf.io/dvkpr). Drawing on a representative sample of 40 x-phi studies published between 2003 and 2015, we enlisted 20 research teams across 8 countries to conduct a high-quality replication of each study in order to compare the results to the original published findings. We found that x-phi studies – as represented in our sample – successfully replicated about 70% of the time. We discuss possible reasons for this relatively high replication rate in the field of experimental philosophy and offer suggestions for best research practices going forward.


Journal ArticleDOI
TL;DR: In this article, the authors examined how pre-and post-diagnosis physical activity was associated with survival outcomes in high-risk breast cancer patients and found that lower volumes of regular activity were associated with similar overall survival advantages as meeting and exceeding the guidelines.
Abstract: Background Although physical activity has been consistently associated with reduced breast cancer mortality, evidence is largely based on data collected at one occasion. We examined how pre- and postdiagnosis physical activity was associated with survival outcomes in high-risk breast cancer patients. Methods Included were 1340 patients enrolled in the Diet, Exercise, Lifestyle and Cancer Prognosis (DELCaP) Study, a prospective study of lifestyle and prognosis ancillary to a SWOG clinical trial (S0221). Activity before diagnosis, during treatment, and at 1- and 2-year intervals after enrollment was collected. Patients were categorized according to the Physical Activity Guidelines for Americans as meeting the minimum guidelines (yes/no) and incrementally as inactive, low active, moderately active (meeting the guidelines), or high active. Results In joint-exposure analyses, patients meeting the guidelines before and 1 year after diagnosis experienced statistically significant reductions in hazards of recurrence (hazard ratio [HR] = 0.59, 95% confidence interval [CI] = 0.42 to 0.82) and mortality (HR = 0.51, 95% CI = 0.34-0.77); associations were stronger at 2-year follow-up for recurrence (HR = 0.45, 95% CI = 0.31 to 0.65) and mortality (HR = 0.32, 95% CI = 0.19 to 0.52). In time-dependent analyses, factoring in activity from all time points, we observed striking associations with mortality for low- (HR = 0.41, 95% CI = 0.24 to 0.68), moderate- (HR = 0.42, 95% CI = 0.23 to 0.76), and high-active patients (HR = 0.31, 95% CI = 0.18 to 0.53). Conclusions Meeting the minimum guidelines for physical activity both before diagnosis and after treatment appears to be associated with statistically significantly reduced hazards of recurrence and mortality among breast cancer patients. When considering activity from all time points, including during treatment, lower volumes of regular activity were associated with similar overall survival advantages as meeting and exceeding the guidelines.

Journal ArticleDOI
TL;DR: In this paper, evidence for Higgs boson decay to a pair of muons was presented, which was performed using proton-proton collision data at 13 TeV, corresponding to an integrated luminosity of 137 fb$−1}, recorded by the CMS experiment at the CERN LHC.
Abstract: Evidence for Higgs boson decay to a pair of muons is presented. This result combines searches in four exclusive categories targeting the production of the Higgs boson via gluon fusion, via vector boson fusion, in association with a vector boson, and in association with a top quark-antiquark pair. The analysis is performed using proton-proton collision data at $ \sqrt{s} $ = 13 TeV, corresponding to an integrated luminosity of 137 fb$^{−1}$, recorded by the CMS experiment at the CERN LHC. An excess of events over the back- ground expectation is observed in data with a significance of 3.0 standard deviations, where the expectation for the standard model (SM) Higgs boson with mass of 125.38 GeV is 2.5. The combination of this result with that from data recorded at $ \sqrt{s} $ = 7 and 8 TeV, corresponding to integrated luminosities of 5.1 and 19.7 fb$^{−1}$, respectively, increases both the expected and observed significances by 1%. The measured signal strength, relative to the SM prediction, is $ {1.19}_{-0.39}^{+0.40}{\left(\mathrm{stat}\right)}_{-0.14}^{+0.15}\left(\mathrm{syst}\right) $. This result constitutes the first evidence for the decay of the Higgs boson to second generation fermions and is the most precise measurement of the Higgs boson coupling to muons reported to date.[graphic not available: see fulltext]


Journal ArticleDOI
TL;DR: In this paper, a novel material for treating blown polypropylene filtration media used in medical-grade masks to impart antimicrobial activity is reported, which can reduce disease transmission, resource consumption, and environmental impact of waste.
Abstract: SARS-CoV-2 and other respiratory viruses spread via aerosols generated by infected people. Face masks can limit transmission. However, widespread use of disposable masks consumes tremendous resources and generates waste. Here, a novel material for treating blown polypropylene filtration media used in medical-grade masks to impart antimicrobial activity is reported. To produce thin copper@ZIF-8 core-shell nanowires (Cu@ZIF-8 NWs), Cu NWs are stabilized using a pluronic F-127 block copolymer, followed by growth of ZIF-8 to obtain uniform core-shell structures. The Cu@ZIF-8 NWs are applied to filtration media by dip coating. Aerosol filtration efficiency decreases upon exposure to ethanol (solvent for dip-coating), but increases with addition of Cu@ZIF-8 NWs. Cu@ZIF-8 NWs shows enhanced antibacterial activity, compared to Cu NWs or ZIF-8 alone, against Streptococcus mutans and Escherichia coli. Antiviral activity against SARS-CoV-2 is assayed using virus-infected Vero E6 cells, demonstrating 55% inhibition of virus replication after 48 h by 1 µg of Cu@ZIF-8 NWs per well. Cu@ZIF-8 NWs' cytotoxicity is tested against four cell lines, and their effect on inflammatory response in A549 cells is examined, demonstrating good biocompatibility. This low-cost, scalable synthesis and straightforward deposition of Cu@ZIF-8 NWs onto filter media has great potential to reduce disease transmission, resource consumption, and environmental impact of waste.

Journal ArticleDOI
TL;DR: The prefrontal cortex (PFC) serves as the chief executive officer of the brain, controlling the highest level cognitive and emotional processes as discussed by the authors, and its local circuits among glutamatergic principal neurons and GABAergic interneurons, as well as its long-range connections with other brain regions, have been functionally linked to specific behaviors.
Abstract: The prefrontal cortex (PFC) serves as the chief executive officer of the brain, controlling the highest level cognitive and emotional processes. Its local circuits among glutamatergic principal neurons and GABAergic interneurons, as well as its long-range connections with other brain regions, have been functionally linked to specific behaviors, ranging from working memory to reward seeking. The efficacy of synaptic signaling in the PFC network is profundedly influenced by monoaminergic inputs via the activation of dopamine, adrenergic, or serotonin receptors. Stress hormones and neuropeptides also exert complex effects on the synaptic structure and function of PFC neurons. Dysregulation of PFC synaptic transmission is strongly linked to social deficits, affective disturbance, and memory loss in brain disorders, including autism, schizophrenia, depression, and Alzheimer's disease. Critical neural circuits, biological pathways, and molecular players that go awry in these mental illnesses have been revealed by integrated electrophysiological, optogenetic, biochemical, and transcriptomic studies of PFC. Novel epigenetic mechanism-based strategies are proposed as potential avenues of therapeutic intervention for PFC-involved diseases. This review provides an overview of PFC network organization and synaptic modulation, as well as the mechanisms linking PFC dysfunction to the pathophysiology of neurodevelopmental, neuropsychiatric, and neurodegenerative diseases. Insights from the preclinical studies offer the potential for discovering new medical treatments for human patients with these brain disorders.

Journal ArticleDOI
TL;DR: In this paper, the authors summarize the basic mechanistic theoretical models about dendrite formation and their effects on the battery performance and provide perspectives conclusions for the development of metal batteries.